Atlas Trials

Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System

Clinical trial NCT07721350 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07721350
Sponsor
Hospices Civils de Lyon
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Multiple Myeloma or Amyloidosis
Start date
2026-10-01
Primary completion
2027-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.